|Year : 2022 | Volume
| Issue : 4 | Page : 671-675
Relationship between vitamin D3 level and body mass index in postmenopausal breast cancer patients
Barrak F Al Obeidy1, Alya A Al Zobair2, Nazar M T Jawher3, Fang Zheng4
1 Department of Molecular Biology, General Health Laboratory, Nineveh Health Dorectorate, Mosul, Iraq
2 Department of Internal Medicine, College of Medicine, University of Mosul, Mosul, Iraq
3 Department of Pathology, College of Medicine, Nineveh University, Mosul, Iraq
4 Center for Gene Diagnosis, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China
|Date of Submission||09-Sep-2022|
|Date of Acceptance||28-Sep-2022|
|Date of Web Publication||09-Jan-2023|
Alya A Al Zobair
Department of Internal Medicine, College of Medicine, University of Mosul, Mosul 00964
Source of Support: None, Conflict of Interest: None
Background: Many studies have shown a relation between vitamin D3 deficiency and breast cancer, others estimated an inverse correlation between vitamin D3 and obesity. Objectives: This study aimed to verify the relation between vitamin D3 level and obesity in postmenopausal breast cancer patients. Materials and Methods: This is a cross-sectional study included seventy-six postmenopausal patients with breast cancers who were diagnosed in the period from January 2020 to February 2022 who were divided into two groups: patients with body mass index (BMI) ≥ 30 and those patients with BMI <30. Vitamin D3 level was estimated and compared between the two groups. We studied the correlation between vitamin D3 level with the age of the patients and the parity. Results: the mean age of the included patients was 61 ± 7.7 years and the mean BMI was 32.3 ± 4.3g/m2. The mean value of vitamin D3 was 15. 0 ± 5. 4 for the patients with BMI ≥ 30 while it was 18.2 ± 4.3 for those patients with BMI <30 and there was a significant difference between the two groups with P = 0.007. Furthermore, patients’ vitamin D3 levels showed significant inverse correlations with their age (P = 0.008) and BMI (P = 0.001). Conclusion: There is consistent evidence that deficiency of vitamin D3 is associated with obesity in breast cancer postmenopausal patient; also, vitamin D3 level has a negative correlation with the age and parity of the patients.
Keywords: Breast cancer, obesity, vitamin D
|How to cite this article:|
Al Obeidy BF, Zobair AA, Jawher NM, Zheng F. Relationship between vitamin D3 level and body mass index in postmenopausal breast cancer patients. Med J Babylon 2022;19:671-5
|How to cite this URL:|
Al Obeidy BF, Zobair AA, Jawher NM, Zheng F. Relationship between vitamin D3 level and body mass index in postmenopausal breast cancer patients. Med J Babylon [serial online] 2022 [cited 2023 Feb 6];19:671-5. Available from: https://www.medjbabylon.org/text.asp?2022/19/4/671/367341
| Introduction|| |
Vitamin D3 is a fat-soluble secosteroid that binds to a specific intracellular receptor called vitamin D receptor “VDR” which is a nuclear protein receptor that once it activated by vitamin D, leading to changes in transcription rate of specific target genes including those involved in maintaining mineral homeostasis in higher vertebrates,, in addition to genes which are playing important roles in vasoregulation, inflammation, and thrombosis The human body acquires the majority of vitamin D from skin after ultraviolet light exposure, (approximatively 80%), while the rest comes from diet, where it can be obtained either from vegetables in the form of vitamin D2 (ergocalciferol) or from food such as dairy products and oily fish, or from vitamin D3 (cholecalciferol) supplements. 25 hydroxy cholecalciferol “25(OH)D” is the main circulating form of vitamin D and is usually estimated to determine the status of vitamin D in the human body.
The deficiency of vitamin D3 is a worldwide health problem, as it is associated with an increased risk for several diseases, including osteoporosis associated fractures, diabetes mellitus,, cardiovascular diseases such as hypertension, and some cancers such as breast cancer Breast cancer has a serious risk for women’s health throughout the world, it’s incidence is increasing during the last few years, according to the Iraqi cancer registry a lot of efforts have been directed to identify the risk factors which could lead to the development of breast cancer; aiming for prevention of its occurrence. Vitamin D is one of the factors that has been studied thoroughly to identify the relationship of its low level with the risk of breast cancer,,, some researchers concluded that keeping higher serum concentration of vitamin D3 could have protective effect against breast cancer,, since calcitriol (the biologicaly active form of vitamin D) can mediate the cell growth inhibition and differentiation by binding with vitamin D receptor in healthy breast cells (VDR).
Obesity is a recognized risk factor for adverse health diseases such as type II diabetes and cardiovascular diseases. The WHO estimates that more than 1 billion people worldwide are obese out of whom 650 million adults, 39 million children and 340 million adolescents, this number is still increasing and by the year 2025, approximately 167 million people (children and adult) will become less healthy because they are obese or overweight.,
There is a close interrelation between vitamin D3 and fatty tissues in both the pathogenic role of vitamin D on the development of obesity and the influence of fatty tissues and obesity on the vitamin D metabolism. In fatty tissues, vitamin D3 increases the concentration of HDL-cholesterol, enhances changes in the adipokine profile such as leptin where vitamin D increases leptin levels which in turn inhibiting hunger, and this will diminish fat storage in adipocytes, in addition insufficiency of vitamin D3 can result in an increase in fat mass by activation of lipogenesis,., Both vitamin D3 deficiency and obesity were associated with increased risk of mammary cancer development.
Aim of the study
The targeted goal of this work was to study the relationship between vitamin D3 level and obesity, through the estimation of BMI, in postmenopausal breast cancer patients.
| Materials and Methods|| |
Study type and design
This is a cross-sectional study.
The study population consisted of seventy-six postmenopausal women, who were presented with signs and symptoms of breast cancer, diagnosed histopathologically to have carcinoma of the breast with stage I, II or III, and attended to private oncology clinic immediately after doing surgical resection of the tumor (mastectomy or lumpectomy) and before giving adjuvant therapy, in the period from January 2020 to February 2022. The exclusion criteria of this study were those patients with history of chronic medical condition, those patient taking D3 supplement or metastatic disease.
Every participant was asked to full a questionnaire about personal and social data including; age, parity, menopausal status, education, place of residence whether urban or rural areas physical activity, and tonics intake including vitamin D supplement, the stage of the tumor at the diagnosis. Patients’ body weight and height were recorded in order to calculate BMI for every patient. BMI = weight (in kg)/ height^2 (in m), A cutoff values of BMI ≥ 30 and <30 were regarded to differentiate between obese and non-obese patients, (BMI between 18.5 to 24.9 kg/m2 regarded as normal weight and between 25 to 29.9 kg/m2 regarded as overweight).
Sampling and laboratory technique
A random blood sample was taken from each patient for assessment of serum vitamin D3 level using the ELFA (Enzyme Linked Fluorescent Assay) technique from bioMérieux (VIDAS® 25 OH Vitamin D Total). According to the Endocrine Society guidelines and based on the reference values of our study’s assay, deficiency of vitamin D3 was defined as level ≤20 ng/l (≤50 nmol/l); vitamin D3 insufficiency was defined as level between 20–30 ng/l (50–75 nmol/l), while optimal vitamin D3 levels were defined as between 30–40 ng/l (75–100 nmol/l).
Statistical analysis of our data was done using SPSS version 20, in which the population characteristics were exhibited as mean ± SD and the descriptive measures were shown as percentage and frequencies. Independent t-test was also used to compare between the patients’ groups. Pearson’s correlation was used to test correlation of vitamin D3 levels in patients with age, BMI and parity. The level of significance used for all analyses was P value ≤ 0.05
This study was conducted based on the principles of ethics that have their origin in the Declaration of Helsinki and it was approved by the scientific committee of training and human development center of Nineveh Health Directorate according to the document number 2022033 date 16 February, 2022 to get this approval.
| Results|| |
The mean age of these patients was 61 ± 7.7 years, mean parity was 4.3 ± 2.4 and BMI was 32.3 ± 4.3 kg/m2 as it is demonstrated in [Table 1]. The data of the patients regarding the stage of breast cancer show that five patients were diagnosed to have stage I (6.6%), forty-one patients were diagnosed to have stage II (53.9%) while thirty patients were diagnosed to have stage III (39.5%) as it is demonstrated in [Figure 1].
Deficiency and insufficiency of vitamin D3 deficiency were reported in fifty-two patients (68.42%) and twenty-two patients (28.95%) respectively, while vitamin D3 sufficiency (30–40 ng/mL) was reported in two patients (2.63%) as it is shown in [Table 2]. By comparing the mean level of serum vitamin D3 between the patients’ group with BMI ≥ 30.00 (n = 41) and those patients group with BMI <30.00 (n = 35) there was a significant decrease in the first group compared to the second group (P = 0.007) as it is shown in [Table 3]. Moreover, patients’ vitamin D3 levels have significant inverse correlation with their age (r=-.302, P = 0.008) and BMI (r=-.375, P = 0.001) while there was no significant correlation with parity, as it is shown in [Table 4].
|Table 2: Frequencies and percentages of the vitamin D3 levels between the patients|
Click here to view
|Table 3: Comparison of mean serum vitamin D3 level between the patients with BMI ≥ 30 and those with BMI <30|
Click here to view
|Table 4: Correlation of vitamin D3 levels in all patients with age, BMI and parity|
Click here to view
| Discussion|| |
We conducted this study on seventy-six postmenopausal breast cancer patients where it shows that deficiency of vitamin D3 is a common finding in breast cancer patients. Many pathophysiological conditions have been studied to uncover their relations to vitamin D status in human body including various neoplastic diseases such as breast cancer. Previous studies demonstrated that vitamin D3 has anti-inflammatory and anti-proliferative effect in the tumors, through its attaching to vitamin D receptor (VDR), and down regulation of vitamin D signaling would take a part in the mammary cancer development and progression and this give a suggestion for the possible use of vitamin D supplementation as preventing agent for breast cancer development in young women.
In addition, this study shows a significant decrease in vitamin D3 level in obese breast cancer patients (BMI ≥ 30.00) compared to the non-obese breast cancer patients (BMI <30.00) and this result is quite expected since, there was a clear inverse association between the obesity and serum vitamin D3 level as many studies have pointed to this fact, and many efforts are going on to elucidate the pathophysiologic mechanism behind this, one of the suggested mechanism is the increase in the vitamin D metabolic clearance in the fatty tissues in a study conducted by Blum M et al, who found that vitamin D3 level was significantly higher in fat tissue compared to serum level of vitamin D3 in obese individuals, in addition, obese and elderly women were found to have less sunlight exposure, which is the most important rout to yield vitamin D activation in human body and this could contribute to low vitamin D3 in such people. Another important mechanism, which becomes evident, is called “ volumetric dilution of vitamin D”, in fact vitamin D was found to be distributed mostly in the muscle and fat in obese people, due to increase in the volume of most body tissue (mainly the fatty tissues) this would result in low level of vitamin D3 in to serum. Furthermore, Drincic A et al. showed that obese people, who had vitamin D deficiency, need more vitamin D supplementation than people with normal-weight to attain the same increment of vitamin D.
Another suggested mechanism for the inverse relation between obesity and low level of vitamin D3 was contributed to the 1α-hydroxylase and the 25-hydroxylase enzymes, which are important enzymes for hydroxylation of vitamin D converting it in to active metabolite 1,25 dihydroxyvitamin D, since the expressions of the genes of these two enzymes (25-hydroxylase CYP2J2 and the 1α-hydroxylase CYP27B1) were shown to be decreased in subcutaneous adipose tissue of obese people which contributed to low level of vitamin D3.
Similar to our result, Imtiaz S and Siddiqui N have found in their study, that deficiency of vitamin D3 was very common among breast cancer women especially those with BMI >30 and consumed that vitamin D3 level was inversely related with high body mass index.
In addition, this study showed that vitamin D3 deficiency is associated with increasing age of the studied population, this result is consistent to the result of many previous studies, one of these studies is a cross-sectional study, done in Thailand, reported that insufficiency of vitamin D was found in one-third of the studied elderly women. This commonly encountered vitamin D3 deficiency in old age people is usually resulted from decreased nutritional vitamin D intake, decreased skin synthesis of vitamin D, and the decreased in the time spent in the outdoors’ activities, and physical activity has been found to increase sun exposure, prevent muscle strength’s loss and mass that are the main determinants of serum vitamin D3 level. Because of the deleterious effect of low vitamin D3 level on the health of elderly people, The European Menopause and Andropause Society (EMAS) recommended to keep serum vitamin D levels at 75–225 nmol/L for elderly people.
This study has some limitations; we had limited data on the current or previous jobs of the patients in addition to the detailed information on the daily physical activities which may have indirect effect regarding the degree of exposure to sunlight, in addition to the samples size as the results would be more precise with larger sample size.
| Conclusion|| |
The data of our study indicate that vitamin D3 level is inversely associated with obesity (BMI ≥ 30) in female breast cancer patients. Furthermore, vitamin D3 has negative relationship with age and this encourage us to recommend vitamin D3 monitoring and supplementation for obese patients with Breast cancer and for elderly.
The authors thank our beloved College of Medicine/University Mosul, College of Medicine/ University of Nineveh, Nineveh health directorate for continuous support.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Jean G, Souberbielle JC, Chazot C Vitamin D in Chronic kidney disease and dialysis patients. Nutrients 2017;9:328.
Brakta S, Diamond JS, Al-Hendy A, Diamond MP, Halder SK Role of vitamin D in uterine fibroid biology. Fertil Steril 2015;104:698-706.
Lee SM, Meyer MB, Benkusky NA, O’Brien CA, Pike JW The impact of VDR expression and regulation in vivo. J Steroid Biochem Mol Biol 2018;177:36-45.
Kassi E, Adamopoulos C, Basdra EK, Papavassiliou AG Role of vitamin D in atherosclerosis. Circulation 2013;128:2517-31.
Holick MF Vitamin D deficiency. N Engl J Med 2007;357:266-81.
Wang H, Chen W, Li D, et al
. Vitamin D and chronic diseases. Aging and disease 2017;8:346-53.
Jager N, Schöpe J, Wagenpfeil S, Bocionek P, Saternus R, Vogt T, et al
. The impact of UV-dose, body surface area exposed and other factors on cutaneous vitamin D synthesis measured as serum 25(OH)D concentration: Systematic review and meta-analysis. Anticancer Res 2018;38:1165-71.
Zhang R, Naughton DP Vitamin D in health and disease: Current perspectives. Nutr J 2010;9:65.
Mithal A, Wahl DA, Bonjour JP, Burckhardt P, Dawson-Hughes B, Eisman JA, et al
; IOF Committee of Scientific Advisors (CSA) Nutrition Working Group. Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int 2009;20:1807-20.
Zhao JG, Zeng XT, Wang J, Liu L Association between calcium or vitamin D supplementation and fracture incidence in community-dwelling older adults: A systematic review and meta-analysis. JAMA 2017;318:2466-82.
Jawad IH, Baiee HA Prevalence of vitamin D deficiency and its correlate with overweight and obesity in community-dwelling old adults. Med j babylon 2020;17:36-40.
Gabryanczyk A, Klimczak S, Szymczak-Pajor I, et al
. Is vitamin D deficiency related to increased cancer risk in patients with type 2 diabetes mellitus? Int J Mol Sci 2021;22:6444.
Judd SE, Nanes MS, Ziegler TR, Wilson PW, Tangpricha V Optimal vitamin D status attenuates the age-associated increase in systolic blood pressure in white americans: Results from the third national health and nutrition examination survey. Am J Clin Nutr 2008;87:136-41.
Al-Khalidi B, Kimball SM, Rotondi MA, Ardern CI Standardized serum 25-hydroxyvitamin D concentrations are inversely associated with cardiometabolic disease in U.S. Adults: A cross-sectional analysis of NHANES, 2001-2010. Nutr J 2017;16:16.
Atoum M, Alzoughool F Vitamin D and breast cancer: Latest evidence and future steps. Breast Cancer (Auckl) 2017;11:1178223417749816.
Iraqi Cancer Registry Center Publications. Baghdad, Iraq: Ministry of Health, Iraqi Cancer Board; 2018. p. 49.
Shekarriz-Foumani R, Khodaie F The correlation of plasma 25-hydroxyvitamin D deficiency with risk of breast neoplasms: A systematic review. Iran J Cancer Prev 2016;9:e4469.
Mohr SB, Gorham ED, Alcaraz JE, Kane CJ, Macera CA, Parsons JK, et al
. Serum 25-hydroxyvitamin D and prevention of breast cancer: Pooled analysis. Anticancer Res 2011;31:2939-48.
Bauer SR, Hankinson SE, Bertone-Johnson ER, Ding EL Plasma vitamin D levels, menopause, and risk of breast cancer: Dose-response meta-analysis of prospective studies. Medicine (Baltimore) 2013;92:123-31.
Jamshidinaeini Y, Akbari ME, Abdollahi M, Ajami M, Davoodi SH Vitamin D status and risk of breast cancer in iranian women: A case-control study. J Am Coll Nutr 2016;35:639-46.
Bernhardt SM, Borges VF, Schedin P Vitamin D as a potential preventive agent for young women’s breast cancer. Cancer Prev Res (Phila) 2021;14:825-38.
Al-yasiry RZ, Jwad MA, Hasan MF, et al
. How Obesity Affects Female Fertility. Med j Babylon 2022;19:111-4. [Full text]
World Health Organization. World Obesity Day 2022 – Accelerating action to stop obesity. 2022 [cited 2022 Mar 4]. Available from: World Obesity Day 2022 – Accelerating action to stop obesity (who.int).
Zakharova I, Klimov L, Kuryaninova V, Nikitina I, Malyavskaya S, Dolbnya S, et al
. Vitamin D insufficiency in overweight and obese children and adolescents. Front Endocrinol (Lausanne) 2019;10:103.
Al-Hussaniy HA, Alburghaif AH, Naji MA Leptin hormone and its effectiveness in reproduction, metabolism, immunity, diabetes, hopes and ambitions. J Med Life 2021;14:600-5.
Weir CB, Jan A, editors. BMI Classification Percentile And Cut Off Points. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022. PMID: 31082114.
Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al
; Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: An endocrine society clinical practice guideline. J Clin Endocrinol Metab 2011;96:1911-30.
LaPorta E, Welsh J Modeling vitamin D actions in triple negative/basal-like breast cancer. J Steroid Biochem Mol Biol 2014;144 Pt A:65-73.
Walsh JS, Bowles S, Evans AL Vitamin D in obesity. Curr Opin Endocrinol Diabetes Obes 2017;24:389-94.
Pereira-Santos M, Costa PR, Assis AM, Santos CA, Santos DB Obesity and vitamin D deficiency: A systematic review and meta-analysis. Obes Rev 2015;16:341-9.
Blum M, Dolnikowski G, Seyoum E, Harris SS, Booth SL, Peterson J, et al
. Vitamin D(3) in fat tissue. Endocrine 2008;33:90-4.
Kull M, Kallikorm R, Lember M Body mass index determines sunbathing habits: Implications on vitamin D levels. Intern Med J 2009;39:256-8.
Heaney RP, Horst RL, Cullen DM, Armas LA Vitamin D3 distribution and status in the body. J Am Coll Nutr 2009;28:252-6.
Drincic A, Fuller E, Heaney RP, Armas LA 25-hydroxyvitamin D response to graded vitamin D3
supplementation among obese adults. J Clin Endocrinol Metab 2013;98:4845-51.
Wamberg L, Christiansen T, Paulsen SK, Fisker S, Rask P, Rejnmark L, et al
. Expression of vitamin D-metabolizing enzymes in human adipose tissue – the effect of obesity and diet-induced weight loss. Int J Obes (Lond) 2013;37:651-7.
Imtiaz S, Siddiqui N Vitamin-D status at breast cancer diagnosis: Correlation with social and environmental factors and dietary intake. J Ayub Med Coll Abbottabad 2014;26:186-90.
Chailurkit LO, Kruavit A, Rajatanavin R Vitamin D status and bone health in healthy thai elderly women. Nutrition 2011;27:160-4.
Pérez-López FR, Brincat M, Erel CT, Tremollieres F, Gambacciani M, Lambrinoudaki I, et al
. EMAS position statement: Vitamin D and postmenopausal health. Maturitas 2012;71:83-8.
[Table 1], [Table 2], [Table 3], [Table 4]